von Willebrand Factor and Factor VIII: C in Acute Cerebrovascular Disease
- 1 June 1997
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 77 (06) , 1104-1108
- https://doi.org/10.1055/s-0038-1656120
Abstract
Background. Elevated von Willebrand factor (vWF) is a risk factor in the development of acute myocardial infarction. The importance of vWF and factor VIII :C in the pathogenesis of cerebrovascular disease (CVD) is poorly defined. Methods and results. We studied 208 cases of stroke whose pathological type was defined by cranial computed tomography. Cerebral infarcts were grouped according to the Oxfordshire Community Stroke Project (OCSP) clinical classification. The results in patients were compared with 184 healthy reference subjects. In patients, vWF and FVIII: C levels were determined initially and after three months. Patients were followed prospectively for six months or until death. Levels of vWF and FVIII :C were elevated initially (1.86 IU/ml and 2.20 U/ml respectively) and after 3 months (1.51 IU/ml and 1.90 U/ml) compared with a healthy reference population (1.26 IU/ml and 1.49 U/ml p = 0.0001). In the initial sample, vWF was associated with age (p = 0.01). FVIII: C was related to age (p = 0.04), gender (p = 0.007 higher for females) and a history of diabetes mellitus (2.56 U/ml vs. 2.16 U/ml in non-diabetics, p = 0.008). Initial vWF levels were higher in subjects with large vessel disease (TACI/PACI) group compared with the small vessel disease (LACI) group [2.12 IU/ml, (n = 112) vs. 1.48 IU/ml (n = 59) respectively, p = 0.0001] and similarly in initial FVIII :C levels (2.43 U/ml vs. 1.87 U/ml, p = 0.0001). Analysis of six-month case fatality, vWF levels were associated with risk of death [p = 0.01, OR 1.73 (1.12,2.66) for an increase of 1 U/ml], even after allowing for stroke type. Conclusion. The relationship of vWF with stroke mortality has not previously been described. Although we have not demonstrated a causal role for vWF in the pathogenesis of CVD, elevated circulating levels of vWF may be associated with increased risk of death following stroke. A prospective study would be required to establish whether vWF is predictive for the development of CVD.Keywords
This publication has 11 references indexed in Scilit:
- Haemostasis Factors in Angina Pectoris; Relation to Gender, Age and Acute-phase ReactionThrombosis and Haemostasis, 1995
- Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina PectorisNew England Journal of Medicine, 1995
- von Willebrand Factor and Cardiovascular DiseaseThrombosis and Haemostasis, 1993
- von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.Heart, 1991
- Classification and natural history of clinically identifiable subtypes of cerebral infarctionPublished by Elsevier ,1991
- The Association of Factor VIII With von Willebrand FactorMayo Clinic Proceedings, 1991
- Coronary artery disease and haemostatic variables in heterozygous familial hypercholesterolaemia.Heart, 1985
- Manifestations of Coronary Disease Predisposing to StrokePublished by American Medical Association (AMA) ,1983
- Self-administration of a questionnaire on chest pain and intermittent claudication.Journal of Epidemiology and Community Health, 1977
- Nervous Regulation of Factor-VIII Levels in ManBritish Journal of Haematology, 1971